Clinical Trials Arena January 23, 2024
The study was designed to assess the equivalence of visual acuity measurements between Tilak Healthcare’s OdySight app, and traditional eyesight checks.
French digital health firm, Tilak Healthcare, has announced positive results from a clinical trial of a mobile app aimed at allowing patients with chronic macular degeneration to monitor their eyesight.
TIL002, a multicentre trial taking place across three French hospitals, demonstrated that theCE-marked OdySight app showed a high level of concordance between itself and traditional methods of testing for eyesight decline.
The app allows patients to carry out regular monitoring of their visual acuity through eye tests that they perform themselves, with the results forwarded to the patient’s clinicians.
...
Today's Sponsors
Today's Sponsor
Topics: Apps, Biotechnology, Clinical Trials, Digital Health, Pharma, Pharma / Biotech, Technology, Trends